Lyst Therapeutics
Columbus
About Lyst Therapeutics
Lyst Therapeutics is a project at Nationwide Children's Research Institute to determine the effect of LYST antibody on inhibiting the formation of tissue engineered vascular graft stenosis.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: $1K – $10K
- Total funding: $400.0K
- Funding stage: Seed
- Last round: Seed (Jul 2017)
- Website: lysttherapeutics.com
Industries & Categories
Health Care, Hospital, Therapeutics
Canonical: https://fsome.com/organization/lyst-therapeutics-214528 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.